U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
XMAB-18087
Preferred Name English
TIDUTAMAB
INN   USAN  
Official Name English
XMAB18087
Code English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD3 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL XMAB18087 .GAMMA.1-CHAIN), (265->231'),(268->234')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN G1, ANTI-(HUMAN SOMATOSTATIN RECEPTOR 2) (HUMAN-MUS MUSCULUS MONOCLONAL XMAB18087 .GAMMA.1-CH
Systematic Name English
IMMUNOGLOBULIN HALF-G1-KAPPA/SCFV-H-CH2-CH3, ANTI-(HOMO SAPIENS SSTR2 (SOMATOSTATIN RECEPTOR 2) AND HOMO SAPIENS CD3 EPSILON (CD3E, LEU-4)), MONOCLONAL ANTIBODY, BISPECIFICGAMMA1 HEAVY CHAIN ANTI-SSTR2 (1-451) (VH (HOMO SAPIENS IGHV3-48*03 (90.8%)-(IGHD)
Systematic Name English
TIDUTAMAB [USAN]
Common Name English
Tidutamab [WHO-DD]
Common Name English
ANTI-SSTR2/CD3 MONOCLONAL ANTIBODY XMAB18087
Common Name English
tidutamab [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C28227
Created by admin on Wed Apr 02 00:23:02 GMT 2025 , Edited by admin on Wed Apr 02 00:23:02 GMT 2025
NCI_THESAURUS C129822
Created by admin on Wed Apr 02 00:23:02 GMT 2025 , Edited by admin on Wed Apr 02 00:23:02 GMT 2025
Code System Code Type Description
NCI_THESAURUS
C146820
Created by admin on Wed Apr 02 00:23:02 GMT 2025 , Edited by admin on Wed Apr 02 00:23:02 GMT 2025
PRIMARY
CAS
2148354-90-7
Created by admin on Wed Apr 02 00:23:02 GMT 2025 , Edited by admin on Wed Apr 02 00:23:02 GMT 2025
PRIMARY
SMS_ID
300000005939
Created by admin on Wed Apr 02 00:23:02 GMT 2025 , Edited by admin on Wed Apr 02 00:23:02 GMT 2025
PRIMARY
FDA UNII
88635FW2QX
Created by admin on Wed Apr 02 00:23:02 GMT 2025 , Edited by admin on Wed Apr 02 00:23:02 GMT 2025
PRIMARY
USAN
HI-138
Created by admin on Wed Apr 02 00:23:02 GMT 2025 , Edited by admin on Wed Apr 02 00:23:02 GMT 2025
PRIMARY
INN
11022
Created by admin on Wed Apr 02 00:23:02 GMT 2025 , Edited by admin on Wed Apr 02 00:23:02 GMT 2025
PRIMARY
ACTIVE MOIETY
TIDUTAMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966